Risk of primary non-breast cancer after female breast cancer by age at diagnosis

Cancer Epidemiology Biomarkers and Prevention

Volumn 20, Issue 8, 2011, Pages 1784-1792

  Mellemkjær, Lene ^a   Christensen, Jane ^a   Frederiksen, Kirsten ^a   Pukkala, Eero ^c   Weiderpass, Elisabete ^d,e,f   Bray, Freddie ^e,g   Friis, Srøen ^a   Andersson, Michael ^b   Olsen, Jørgen H ^a  

^a INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^b FINSEN LABORATORY   (Denmark)

^c FINNISH CANCER REGISTRY   (Finland)

^d FOLKHÄLSAN RESEARCH CENTER   (Finland)

^e CANCER REGISTRY OF NORWAY   (Norway)

^f KAROLINSKA INSTITUTE   (Sweden)

^g INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER RISK; DENMARK; ENDOMETRIUM CANCER; FEMALE; FINLAND; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; NORWAY; POISSON DISTRIBUTION; PRIMARY TUMOR; PRIORITY JOURNAL; RISK FACTOR;

ADULT; AGE FACTORS; AGED; BREAST NEOPLASMS; DENMARK; FEMALE; FINLAND; HUMANS; MIDDLE AGED; NORWAY; RISK FACTORS;

EID: 79961214165     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-11-0009     Document Type: Article

References (33)

1. Parkin DM, Fernandez LM. Use of statistics to assess the global burden of breast cancer. Breast J 2006;12 Suppl 1:S70-80. (Pubitemid 43385274)
2. Sant M, Allemani C, Santaquilani M, Knijn A, Marchesi F, Capocaccia R. EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary. Eur J Cancer 2009;45:931-91.
3. Curtis RE, Ron E, Hankey BF, Hoover RN. New malignancies following breast cancer. In: Curtis RE, Freedman DM, Ron E, Ries LAG, Hacker DG, Edwards BK, et al., editors. New malignancies among cancer survivors: SEER Cancer Registries, 1973-2000. Bethesda, MD: National Cancer Institute; 2006. p. 181-205.
4. Schaapveld M, Visser O, Louwman MJ, de Vries EG, Willemse PH, Otter R, et al. Risk of new primary nonbreast cancers after breast cancer treatment: a Dutch population-based study. J Clin Oncol 2008;26:1239-46.
5. Lee KD, Chen SC, Chan CH, Lu CH, Chen CC, Lin JT, et al. Increased risk for second primary malignancies in women with breast cancer diagnosed at young age: a population-based study in Taiwan. Cancer Epidemiol Biomarkers Prev 2008;17:2647-55.
6. Evans HS, Lewis CM, Robinson D, Bell C, Møller H, Hodgson SV. Incidence of multiple primary cancers in a cohort of women diagnosed with breast cancer in southeast England. Br J Cancer 2001;84:435-40. (Pubitemid 32154442)
7. Rubino C, de Vathaire F, Diallo I, Shamsaldin A, Le MG. Increased risk of second cancers following breast cancer: role of the initial treatment. Breast Cancer Res Treat 2000;61:183-95. (Pubitemid 30609552)
8. Mellemkjaer L, Friis S, Olsen JH, Scelo G, Hemminki K, Tracey E, et al. Risk of second cancer among women with breast cancer. Int J Cancer 2006;118:2285-92.
9. Brown LM, Chen BE, Pfeiffer RM, Schairer C, Hall P, Storm H, et al. Risk of second non-hematological malignancies among 376,825 breast cancer survivors. Breast Cancer Res Treat 2007;106:439-51. (Pubitemid 350029686)
10. Teppo L, Pukkala E, Sax-en E. Multiple cancer-an epidemiologic exercise in Finland. J Natl Cancer Inst 1985;75:207-17. (Pubitemid 15229326)
11. Andersson M, Jensen MB, Engholm G, Henrik SH. Risk of second primary cancer among patients with early operable breast cancer registered or randomised in Danish Breast Cancer Cooperative Group (DBCG) protocols of the 77, 82 and 89 programmes during 1977-2001. Acta Oncol 2008;47:755-64. (Pubitemid 351878439)
12. Volk N, Pompe-Kirn V. Second primary cancers in breast cancer patients in Slovenia. Cancer Causes Control 1997;8:764-70. (Pubitemid 27404647)
13. Buiatti E, Crocetti E, Acciai S, Gaf-a L, Falcini F, Milandri C, et al. Incidence of second primary cancers in three Italian population-based cancer registries. Eur J Cancer 1997;33:1829-34. (Pubitemid 28129212)
14. Murakami H, Hiyama T, Hanai A, Fujimoto I. Second primary cancers following female breast cancer in Osaka, Japan-a population-based cohort study. Jpn J Clin Oncol 1987;17:293-302.
15. Harvey EB, Brinton LA. Second cancer following cancer of the breast in Connecticut, 1935-82. Natl Cancer Inst Monogr 1985;68:99-112. (Pubitemid 16233726)
16. Fredholm H, Eaker S, Frisell J, Holmberg L, Fredriksson I, Lindman H. Breast cancer in young women: poor survival despite intensive treatment. PLoS One 2009;4:e7695.
17. Sundhedsstyrelsen. Cancerregisteret 2007. København 2009. http://www.sst.dk/publ/Publ2009/DOKU/cancerreg/cancerregister2007.pdf.
18. Storm H, Michelsen EV, Clemmensen IH, Pihl J. The Danish Cancer Registry. Dan Med Bull 1997;44:549-53.
19. Pukkala E. Finland-cancer registration. In: Pukkala E, Söderman B, Okeanov A, Storm HH, Rahu M, Hakulinen T, et al., editors. Cancer atlas of Northern Europe. Helsinki, Finland: Cancer Society of Finland Publication 62; 2001. p. 50-1.
20. Cancer Registry of Norway. Cancer in Norway 2005. Oslo: 2006.
21. Smith RE. Risk for the development of treatment-related acute myelocytic leukemia and myelodysplastic syndrome among patients with breast cancer: review of the literature and the National Surgical Adjuvant Breast and Bowel Project experience. Clin Breast Cancer 2003;4:273-9. (Pubitemid 37526972)
22. Cuzick J, Powles T, Veronesi U, Forbes J, Edwards R, Ashley S, et al. Overview of the main outcomes in breast-cancer prevention trials. Lancet 2003;361:296-300. (Pubitemid 36126189)
23. Welcsh PL, King MC. BRCA1 and BRCA2 and the genetics of breast and ovarian cancer. Hum Mol Genet 2001;10:705-13. (Pubitemid 32331579)
24. Marshall JR, Freudenheim J. Alcohol. 3rd ed. In: Schottenfeld D, Fraumeni JF Jr, editors. Cancer epidemiology and prevention. New York: Oxford University Press; 2006. p. 243-58.
25. World Cancer Research Fund/American Institute for Cancer Research. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Washington, DC: AICR; 2007.
26. Hsing AW, Rashid A, Devesa SS, Fraumeni JF Jr. Biliary tract cancer 3rd ed. In: Schottenfeld D, Fraumeni JF Jr editors. Cancer epidemiology and prevention. New York: Oxford University Press; 2006. p. 787-800.
27. Lindor NM, Lindor CJ, Greene MH. Hereditary neoplastic syndromes. 3rd ed. In: Schottenfeld D, Fraumeni JF Jr editors. Cancer epidemiology and prevention New York: Oxford University Press; 2006. p. 562-76.
28. Curtis RE, Boice JD Jr, Stovall M, Bernstein L, Greenberg RS, Flannery JT, et al. Risk of leukemia after chemotherapy and radiation treatment for breast cancer. N Engl J Med 1992;326:1745-51.
29. Ibrahim NK. Leukemogenic effect of chemotherapy in patients with breast carcinoma: is it a real concern? Cancer 2004;101:1479-81. (Pubitemid 39318891)
30. Berrington de GA, Curtis RE, Gilbert E, Berg CD, Smith SA, Stovall M, et al. Second solid cancers after radiotherapy for breast cancer in SEER cancer registries. Br J Cancer 2010;102:220-6.
31. Boice JD Jr, Harvey EB, Blettner M, Stovall M, Flannery JT. Cancer in the contralateral breast after radiotherapy for breast cancer. N Engl J Med 1992;326:781-5.
32. Stovall M, Smith SA, Langholz BM, Boice JD Jr, Shore RE, Andersson M, et al. Dose to the contralateral breast from radiotherapy and risk of second primary breast cancer in the WECARE study. Int J Radiat Oncol Biol Phys 2008;72:1021-30.
33. Goggins W, Gao W, Tsao H. Association between female breast cancer and cutaneous melanoma. Int J Cancer 2004;111:792-4. (Pubitemid 39062905)